These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7742347)

  • 1. Glucagon receptors: from genetic structure and expression to effector coupling and biological responses.
    Christophe J
    Biochim Biophys Acta; 1995 May; 1241(1):45-57. PubMed ID: 7742347
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucagon and its receptor in various tissues.
    Christophe J
    Ann N Y Acad Sci; 1996 Dec; 805():31-42; discussion 42-3. PubMed ID: 8993391
    [No Abstract]   [Full Text] [Related]  

  • 3. Cloning and expression of a human glucagon receptor.
    MacNeil DJ; Occi JL; Hey PJ; Strader CD; Graziano MP
    Biochem Biophys Res Commun; 1994 Jan; 198(1):328-34. PubMed ID: 7507321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning and characterization of the glucagon receptor from cynomologous monkey.
    McNally T; Grihalde ND; Pederson TM; Ogiela CA; Djuric SW; Collins CA; Lin CW; Reilly RM
    Peptides; 2004 Jul; 25(7):1171-8. PubMed ID: 15245877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, purification and preliminary characterization of glucagon receptor extracellular domain.
    Wu L; Zhai Y; Lu J; Wang Q; Sun F
    Protein Expr Purif; 2013 Jun; 89(2):232-40. PubMed ID: 23597780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon and GLP-1 receptors: lessons from chimeric ligands and receptors.
    Hjorth SA; Schwartz TW
    Acta Physiol Scand; 1996 Jul; 157(3):343-5. PubMed ID: 8830889
    [No Abstract]   [Full Text] [Related]  

  • 7. Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo.
    Yang X; Yates ML; Candelore MR; Feeney W; Hora D; Kim RM; Parmee ER; Berger JP; Zhang BB; Qureshi SA
    Eur J Pharmacol; 2007 Jan; 555(1):8-16. PubMed ID: 17140563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon receptors.
    Authier F; Desbuquois B
    Cell Mol Life Sci; 2008 Jun; 65(12):1880-99. PubMed ID: 18292967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse.
    Campos RV; Lee YC; Drucker DJ
    Endocrinology; 1994 May; 134(5):2156-64. PubMed ID: 8156917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positively charged residues at positions 12, 17, and 18 of glucagon ensure maximum biological potency.
    Unson CG; Wu CR; Cheung CP; Merrifield RB
    J Biol Chem; 1998 Apr; 273(17):10308-12. PubMed ID: 9553084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
    Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action.
    Day JW; Li P; Patterson JT; Chabenne J; Chabenne MD; Gelfanov VM; Dimarchi RD
    J Pept Sci; 2011 Mar; 17(3):218-25. PubMed ID: 21308878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular aspects of the glucagon receptor: role in diabetes and metabolism.
    Burcelin R; Katz EB; Charron MJ
    Diabetes Metab; 1996 Dec; 22(6):373-96. PubMed ID: 8985646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biology of glucagon and the consequences of hyperglucagonemia.
    Wewer Albrechtsen NJ; Kuhre RE; Pedersen J; Knop FK; Holst JJ
    Biomark Med; 2016 Nov; 10(11):1141-1151. PubMed ID: 27611762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
    Al-Sabah S; Donnelly D
    Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants of glucagon receptor signaling.
    Unson CG
    Biopolymers; 2002; 66(4):218-35. PubMed ID: 12491536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucagon, GLP].
    Matsuyama T; Kuwajima M
    Nihon Rinsho; 1997 Oct; 55 Suppl():133-41. PubMed ID: 9392102
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of key residues for the binding of glucagon to the N-terminal domain of its receptor: an alanine scan and modeling study.
    Prévost M; Vertongen P; Waelbroeck M
    Horm Metab Res; 2012 Oct; 44(11):804-9. PubMed ID: 22893257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon receptor antagonists for the treatment of type II diabetes: current prospects.
    Djuric SW; Grihalde N; Lin CW
    Curr Opin Investig Drugs; 2002 Nov; 3(11):1617-23. PubMed ID: 12476962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies on positions 17, 18, and 21 replacement analogues of glucagon: the importance of charged residues and salt bridges in glucagon biological activity.
    Sturm NS; Lin Y; Burley SK; Krstenansky JL; Ahn JM; Azizeh BY; Trivedi D; Hruby VJ
    J Med Chem; 1998 Jul; 41(15):2693-700. PubMed ID: 9667960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.